Primary immunodeficiency as a cause of immune-mediated kidney diseases
Nephrology Dialysis Transplantation · 30.10.2024 · 39 (11) · 1772-1784
DOI: 10.1093/ndt/gfae117 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 21.05.2024. Verfasst von Changming Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Kidney Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Primary immunodeficiency (PID) is no longer defined by infections alone, and autoimmunity is an accompanying manifestation of PID. Recurrent infections may trigger autoimmunity through molecular mimicry, bystander activation or superantigens. The diagnosis of PID is still challenging, but genetic analysis reveals the underlying link between PID and autoimmunity. Mutations in relevant genes affecting central and peripheral immune tolerance, regulatory T-cell function, expansion of autoreactive lymphocytes, antigen clearance, hyperactivation of type I interferon and nuclear factor-κB pathways have all been implicated in triggering autoimmunity in PID. Autoimmunity in PID leads to chronic inflammation, tissue damage and organ failure, and increases the mortality of patients with PID. The kidneys are inextricably linked with the immune system, and kidney diseases can be mediated by both infection and autoimmunity/inflammation in PID patients. The manifestations of kidney involvement in PID patients are very heterogeneous and include lupus nephritis, C3 glomerulopathy, kidney thrombotic microangiopathy, vasculitis and interstitial nephritis. Patients with PID-caused kidney diseases have defined immune function defects and may benefit from pathway-based biologics, stem cell transplantation or gene therapy. Early diagnosis and appropriate treatment of PID are crucial for reducing the mortality rate and improving organ function and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
ORCID-Profile: Zhihong Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, C., Liang, D., & Liu, Z. (2024). Primary immunodeficiency as a cause of immune-mediated kidney diseases. Nephrology Dialysis Transplantation, 39(11), 1772-1784. https://doi.org/10.1093/ndt/gfae117
Vancouver
Zhang C, Liang D, Liu Z. Primary immunodeficiency as a cause of immune-mediated kidney diseases. Nephrology Dialysis Transplantation. 2024;39(11):1772-1784. doi:10.1093/ndt/gfae117
BibTeX
@article{Zhang2024,
author = {Zhang, Changming and Liang, Dandan and Liu, Zhihong},
title = {Primary immunodeficiency as a cause of immune-mediated kidney diseases},
journal = {Nephrology Dialysis Transplantation},
year = {2024},
volume = {39},
number = {11},
pages = {1772--1784},
doi = {10.1093/ndt/gfae117}
}
EUVIMED